These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24386967)

  • 1. Biomarkers of treatment response in multiple sclerosis.
    Buck D; Hemmer B
    Expert Rev Neurother; 2014 Feb; 14(2):165-72. PubMed ID: 24386967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis: individualized disease susceptibility and therapy response.
    Pravica V; Markovic M; Cupic M; Savic E; Popadic D; Drulovic J; Mostarica-Stojkovic M
    Biomark Med; 2013 Feb; 7(1):59-71. PubMed ID: 23387485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?].
    Fontaine B
    Rev Neurol (Paris); 2012 Nov; 168(11):833-5. PubMed ID: 22959703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of biomarkers in multiple sclerosis.
    Bielekova B; Martin R
    Brain; 2004 Jul; 127(Pt 7):1463-78. PubMed ID: 15180926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for multiple sclerosis.
    Villoslada P
    Drug News Perspect; 2010 Nov; 23(9):585-95. PubMed ID: 21152453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From bench to MS bedside: challenges translating biomarker discovery to clinical practice.
    Rajasekharan S; Bar-Or A;
    J Neuroimmunol; 2012 Jul; 248(1-2):66-72. PubMed ID: 22381245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.
    Dagley LF; Emili A; Purcell AW
    Proteomics Clin Appl; 2013 Jan; 7(1-2):91-108. PubMed ID: 23112123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body fluid biomarkers for multiple sclerosis--the long road to clinical application.
    Teunissen CE; Malekzadeh A; Leurs C; Bridel C; Killestein J
    Nat Rev Neurol; 2015 Oct; 11(10):585-96. PubMed ID: 26392381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH; Naismith RT
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pediatric multiple sclerosis and variants.
    Pohl D; Waubant E; Banwell B; Chabas D; Chitnis T; Weinstock-Guttman B; Tenembaum S;
    Neurology; 2007 Apr; 68(16 Suppl 2):S54-65. PubMed ID: 17438239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment optimisation in multiple sclerosis.
    Zaffaroni M
    Neurol Sci; 2005 Dec; 26 Suppl 4():S187-92. PubMed ID: 16388356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options in multiple sclerosis: five new things.
    Miravalle A; Corboy JR
    Neurology; 2010 Nov; 75(18 Suppl 1):S22-7. PubMed ID: 21041767
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy of multiple sclerosis--current practice and future directions.
    Tullman MJ; Lublin FD; Miller AE
    J Rehabil Res Dev; 2002; 39(2):273-85. PubMed ID: 12051470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of multiple sclerosis and treatment decisions.
    Siva A
    Clin Neurol Neurosurg; 2006 Mar; 108(3):333-8. PubMed ID: 16378680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.
    Koch MW; Metz LM; Kovalchuk O
    Trends Mol Med; 2013 Jan; 19(1):23-30. PubMed ID: 23153574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.
    Fawaz CN; Makki IS; Kazan JM; Gebara NY; Andary FS; Itani MM; El-Sayyed M; Zeidan A; Quartarone A; Darwish H; Mondello S
    Expert Rev Proteomics; 2015; 12(6):637-50. PubMed ID: 26479122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics technologies for biomarker discovery in multiple sclerosis.
    Singh V; Hintzen RQ; Luider TM; Stoop MP
    J Neuroimmunol; 2012 Jul; 248(1-2):40-7. PubMed ID: 22129845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilaments as biomarkers in multiple sclerosis.
    Teunissen CE; Khalil M
    Mult Scler; 2012 May; 18(5):552-6. PubMed ID: 22492131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping and distinct mechanisms of action of multiple sclerosis therapies.
    Graber JJ; McGraw CA; Kimbrough D; Dhib-Jalbut S
    Clin Neurol Neurosurg; 2010 Sep; 112(7):583-91. PubMed ID: 20627553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.